Monthly Archives: November 2019

//November

Professor David Wright to lead independent review into PSNC and LPC representation and support for contractors

David Wright, Professor of Pharmacy Practice from the School of Pharmacy at the University of East Anglia has been appointed to lead an independent review of the roles and structures underpinning PSNC and the LPCs. The review has been called at a time when the community pharmacy landscape is rapidly changing and local representation and...

By |November 29th, 2019|Lexpos News|Comments Off on Professor David Wright to lead independent review into PSNC and LPC representation and support for contractors

Professor David Wright to lead independent review into PSNC and LPC representation and support for contractors

David Wright, Professor of Pharmacy Practice from the School of Pharmacy at the University of East Anglia has been appointed to lead an independent review of the roles and structures underpinning PSNC and the LPCs. The review has been called at a time when the community pharmacy landscape is rapidly changing and local representation and...

By |November 29th, 2019|Lexpos News|Comments Off on Professor David Wright to lead independent review into PSNC and LPC representation and support for contractors

GPhC welcomes audit on valproate medicines safety in community pharmacy

Duncan Rudkin, Chief Executive of the GPhC said: 

“The CCA’s findings provide evidence of some improvement between 2018 and 2019 in terms of pharmacy teams’ awareness of the need to follow the Pregnancy Prevention Programme (PPP) for valproate, but it is clear there is still more to be done.
 

By |November 29th, 2019|Lexpos News|Comments Off on GPhC welcomes audit on valproate medicines safety in community pharmacy

GPhC welcomes audit on valproate medicines safety in community pharmacy

Duncan Rudkin, Chief Executive of the GPhC said: 

“The CCA’s findings provide evidence of some improvement between 2018 and 2019 in terms of pharmacy teams’ awareness of the need to follow the Pregnancy Prevention Programme (PPP) for valproate, but it is clear there is still more to be done.
 

By |November 29th, 2019|Lexpos News|Comments Off on GPhC welcomes audit on valproate medicines safety in community pharmacy

GPhC welcomes audit on valproate medicines safety in community pharmacy

Duncan Rudkin, Chief Executive of the GPhC said: 

“The CCA’s findings provide evidence of some improvement between 2018 and 2019 in terms of pharmacy teams’ awareness of the need to follow the Pregnancy Prevention Programme (PPP) for valproate, but it is clear there is still more to be done.
 

By |November 29th, 2019|Lexpos News|Comments Off on GPhC welcomes audit on valproate medicines safety in community pharmacy